Khuroo A

No ORCID on file · 2 papers in corpus · active 2019-2026

Study types

  • rct 1

Condition tags

  • endometriosis 1
rct 2026
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions
Clinical pharmacology in drug development ·doi:10.1002/cpdd.70053

Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical d…

2019
Abstracts of the Annual Meeting of the Iuliu Haţieganu, University of Medicine and Pharmacy : 3rd – 7th December 2018, Cluj-Napoca
Medicine and pharmacy reports